Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Change in Receivables (2024 - 2025)

Historic Change in Receivables for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to $17000.0.

  • Connect Biopharma Holdings' Change in Receivables fell 9966.14% to $17000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.0 million, marking a year-over-year change of. This contributed to the annual value of $789000.0 for FY2024, which is N/A changed from last year.
  • Per Connect Biopharma Holdings' latest filing, its Change in Receivables stood at $17000.0 for Q3 2025, which was down 9966.14% from -$8000.0 recorded in Q2 2025.
  • In the past 5 years, Connect Biopharma Holdings' Change in Receivables registered a high of $5.0 million during Q3 2024, and its lowest value of -$4.2 million during Q4 2024.